Bar chart showing that a majority of Americans across demographic groups have heard at least a little about Ozempic, Wegovy and other similar drugs. Just 25% of U.S. adults have heard nothing at all.
Table showing Americans’ views of Ozempic, Wegovy and other similar drugs as options for weight loss. Across demographic groups, Americans are far more likely to say these drugs are good options for people with obesity or a weight-related health condition than for those with no such condition who just want to lose weight.